References
- Audus K. L., Gordon M. A. J. Imnunopharmacol., in press
- Frazer A. Neuropharmacology of the Central Nervous System and Behavioral Disorders, Palmer. Academic Press, New York, New York, 74
- Kostowski W. Brain Noradrenaline, Depression, and Antidepressant Drugs: Facts and Hypothesis. Trends Pharmacol. Sci. 1981; 2: 314
- Strom T. B., Carpenter C. B. Cyclic Nucleotides in Immunosuppression-Neuroendocrine Pharmacologic Manipulation and In Vivo Immunoregulation of Immunity Acting via Second Messenger Systems. Transplant Proc. 1980; 12: 304
- Gordon M. A., Cohen J. J., Wilson I. B. Muscarinic Cholinergic Receptors in Murine Lymphocytes: Demonstration by Direct Binding. Proc. Natl. Acad. Sci. USA 1978; 75: 2902
- Richman D. P., Arnason B. G. W. Nicotinic Acetylcholine Receptor: Evidence for a Functionally Distinct Receptor on Human Lymphocytes. Proc. Natl. Acad. Sci. USA 1979; 76: 4632
- Hadden J. W., Hadden E. M., Middleton E., Jr. Lymphocyte Blast Transformation. I. Demonstration of Adrenergic Receptors in Human Peripheral Lymphocytes. J. Cell. Imnunol. 1970; 1: 583
- Johnson D. L., Gordon M. A. Characteristics of Beta-Adrenergic Binding Sites Associated with Murine Lymphocytes Isolated from Spleen. J. Immunopharmacol. 1980; 2: 435
- Davis P. B., Shelhamer J. R., Kaliner M. Abnormal Adrenergic and Cholinergic Sensitivity in Cystic Fibrosis. N. Eng. J. Med. 1980; 302: 1453
- Johnson D. L., Gordon M. A. Effect of Chronic Beta-Adrenergic Therapy on the Human Lymphocyte Response to Concanavalin A. Res. Commun. Chem. Path. Pharmacol. 1981; 32(2)377
- Bevington P. R. Data Reduction and Error Analysis for the Physical Sciences. McGraw-Hill, New York, NY 1969
- Wedner H. J., Parker C. W. Lymphocyte Activation. Prog. Allergy 1976; 20: 195
- Johnson D. L., Ashmore R. C., Gordon M. A. Effects of β-Adrenergic Agents on the Murine Lymphocyte Response to Mitogen Stimulation. J. Immunopharmacol. 1981; 3(2)205
- Dulis B., Gordon M. A., Wilson I. B. Identification of Muscarinic Binding Sites in Human Neutrophils by Direct Binding. Mol. Pharmacol. 1979; 15: 28
- Lee C. M., Snyder S. H. Norepinephrine Neuronal Uptake Binding Sites in Rat Brain Membranes Labeled with [3H]Desipramine. Proc. Natl. Acad. Sci. USA 1981; 78(8)5250
- Rehavi M., Skolnick P., Hulihan B., Paul S. M. High Affinity Binding of (3H)Desipramine to Rat Cerebral Cortex: Relationship to Tricyclic Antidepressant-Induced Inhibition of Norepinephrine Uptake. European J. Pharmacol. 1981; 70: 597
- Sette M., Raisman R., Briley M., Langer S. Z. Localisation of Tricyclic Antidepressant Binding Sites on Serotonin Nerve Terminals. J. Neurochem. 1981; 37: 40
- Rehavi M., Paul S. M., Skolnick P., Goodwin F. K. Demonstration of Specific High Affinity Binding Sites for (3H)Imipramine in Human Brain. Life Sci. 1980; 26: 2273
- Paul S. M., Rehavi M., Skolnick P., Goodwin F. K. Demonstration of Specific “High Affinity” Binding Sites for (3H)Imipramine on Human Platelets. Life Sci. 1980; 26: 953
- Briley M. S., Raisman R., Langer S. Z. Human Platelets Possess High-Affinity Binding Sites for3H-Imipramine. European J. Pharmacol. 1979; 58: 347
- Raisman R., Briley M., Langer S. Z. Specific Tricyclic Antidepressant Binding Sites in Rat Brain. Nature 1979; 281: 148
- Toyoshima S., Makoto I., Toshiaki O. Kinetics of Lymphocyte Stimulation by Concanavalin A. Nature 1976; 264: 447
- Andersson J., Sjöberg O., Möller G. Reversibility of High Dose Unresponsiveness to Concanavalin A in Thymus Lymphocytes. Immunology, Lond. 1972; 23: 637